Novo Nordisk A/S (B Shares) ADRhedged (NVOH) price, chart and fund profile
Price chart
Fund profile
NVOH provides exposure to Novo Nordisk A/S (B Shares) ADR, while using swaps to hedge daily currency fluctuations. The fund aims to provide the total return performance of Novo Nordisk A/S (B Shares), in its local market, to US investors.
- Issuer
- Precidian Funds LLC
- Industry
- Healthcare
- Inception
- Jan 2, 2025
- Expense ratio
- 0.19%
- Net asset value
- $21.83
- NAV as of
- Oct 9, 2026
- Leverage
- 1×
- Fund page
- adrhedged.com↗
Frequently asked questions
What is Novo Nordisk A/S (B Shares) ADRhedged (NVOH)?
NVOH provides exposure to Novo Nordisk A/S (B Shares) ADR, while using swaps to hedge daily currency fluctuations. The fund aims to provide the total return performance of Novo Nordisk A/S (B Shares), in its local market, to US investors.
What is NVOH's expense ratio?
Novo Nordisk A/S (B Shares) ADRhedged charges an annual expense ratio of 0.19%. The fund is issued by Precidian Funds LLC.
How large is NVOH?
Novo Nordisk A/S (B Shares) ADRhedged manages $3.7M in assets and has traded since Jan 2, 2025.
How do I buy shares of Novo Nordisk A/S (B Shares) ADRhedged (NVOH)?
NVOH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
